|Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 591 active entries
Genavenir 8 - 5, rue Henri Desbručres
Phone: +33 1 60 91 21 21
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Biomehodes is a technological leader in directed evolution and protein engineering.
We have developed Massive Mutagenesis®, the only high throughput combinatorial site-directed mutagenesis technology, with a main application to direct molecular evolution of industrial enzymes and therapeutic proteins.
This technology allows the generation of complex protein variants at a high throughput and has been widely validated through over 30 research projects.
Molecular Evolution; Mutagenesis; High-throughput Screening; Bioinformatics; Industrial Enzymes
Therapeutic Proteins; Recombinant Antibodies
Last update of this entry: November 15, 2005
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking